Literature DB >> 1995085

Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study.

L E DeLisi1, A L Hoff, J E Schwartz, G W Shields, S N Halthore, S M Gupta, F A Henn, A K Anand.   

Abstract

Brain morphology was examined using magnetic resonance imaging in 30 first-episode patients with a schizophreniclike psychosis, 15 chronic schizophrenics, and 20 neurological controls. Statistical analyses of computer-generated measurements of regions of interest were controlled for gender, age, social class, and total brain volume. Lateral ventricular size was increased in both first-episode and chronic schizophrenic patients, with greater significance on the left than on the right side. Only the chronic patients, however, had reduced temporal lobe size, which also was greater on the left side. No major correlations of regional brain morphological measurements with cognitive functioning were found, although some measurements of verbal memory were correlated with parahippocampal size. This is a report of a preliminary study that suggests that some morphological brain changes may be present at the time of first treatment for a psychotic illness, whereas others may occur later in the course of illness. Future prospective studies may determine the clinical significance of these changes and whether they progress with the development of illness chronicity.

Entities:  

Mesh:

Year:  1991        PMID: 1995085     DOI: 10.1016/0006-3223(91)90044-m

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  35 in total

Review 1.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.

Authors:  C Konradi; S Heckers
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

Review 2.  MRI anatomy of schizophrenia.

Authors:  R W McCarley; C G Wible; M Frumin; Y Hirayasu; J J Levitt; I A Fischer; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

3.  Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data.

Authors:  Martha E Shenton; Guido Gerig; Robert W McCarley; Gábor Székely; Ron Kikinis
Journal:  Psychiatry Res       Date:  2002-08-20       Impact factor: 3.222

4.  Functional motor asymmetries correlated with clinical findings in unmedicated schizophrenic patients.

Authors:  I Gorynia; R Uebelhack
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

Review 5.  Review of the operational definition for first-episode psychosis.

Authors:  Nicholas J K Breitborde; Vinod H Srihari; Scott W Woods
Journal:  Early Interv Psychiatry       Date:  2009-11       Impact factor: 2.732

6.  Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia.

Authors:  Babak A Ardekani; Arthika Bappal; Debra D'Angelo; Manzar Ashtari; Todd Lencz; Philip R Szeszko; Pamela D Butler; Daniel C Javitt; Kelvin O Lim; Jan Hrabe; Jay Nierenberg; Craig A Branch; Matthew J Hoptman
Journal:  Neuroreport       Date:  2005-09-08       Impact factor: 1.837

7.  Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia.

Authors:  Vicente Molina; Javier Sanz; Fernando Sarramea; Rogelio Luque; Carlos Benito; Tomás Palomo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-09-14       Impact factor: 5.270

Review 8.  Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

Authors:  Jiri Horacek; Vera Bubenikova-Valesova; Milan Kopecek; Tomas Palenicek; Colleen Dockery; Pavel Mohr; Cyril Höschl
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 9.  The pathobiology of lost human potential: schizophrenia as a neurodevelopmental disorder.

Authors:  J L Waddington
Journal:  Ir J Med Sci       Date:  1991-12       Impact factor: 1.568

Review 10.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.